These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 4395481

  • 1. Beta-adrenergic blocking therapy in hypertension: selection of patients.
    Frohlich ED, Tarazi RC, Dustan HP.
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):151-6. PubMed ID: 4395481
    [No Abstract] [Full Text] [Related]

  • 2. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.
    Hansson L.
    Acta Med Scand Suppl; 1973 Dec; 550():1-40. PubMed ID: 4201751
    [No Abstract] [Full Text] [Related]

  • 3. Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum).
    Török E, Istvánffy M, Halmágyi M, Wagner M, Csukás M.
    Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(5):200-7. PubMed ID: 6104634
    [Abstract] [Full Text] [Related]

  • 4. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
    Bjerle P, Jacobsson KA, Agert G.
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
    [No Abstract] [Full Text] [Related]

  • 5. Effects of 4 beta-adrenoceptor blocking drugs on blood pressure and exercise heart rate in hypertension.
    Harry JD, Knapp MF, Linden RJ, Stoker JB, Newcombe C.
    Eur J Cardiol; 1979 Aug; 10(2):131-41. PubMed ID: 38965
    [Abstract] [Full Text] [Related]

  • 6. [Comparative studies on propranolol and practolol].
    Bodem G, Chidsey CA.
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1662-3. PubMed ID: 4150007
    [No Abstract] [Full Text] [Related]

  • 7. [Use of beta-receptor blocking agents in the treatment of arterial hypertension].
    Hilden T, Ibsen H.
    Ugeskr Laeger; 1973 May 17; 135(20):961-4. PubMed ID: 4148294
    [No Abstract] [Full Text] [Related]

  • 8. [Comparison of the hemodynamic effects in man of 2 beta-blockaders: propranolol and practolol].
    Ambrosioni E, Bracchetti D, Russo F, Catizone L, Perri G, Magnani B.
    Boll Soc Ital Cardiol; 1972 May 17; 17(2):91-101. PubMed ID: 4403643
    [No Abstract] [Full Text] [Related]

  • 9. Hemodynamic effects of adrenergic beta-receptor blocking agents.
    Sannerstedt R.
    Adv Clin Pharmacol; 1976 May 17; 11():70-8. PubMed ID: 25571
    [No Abstract] [Full Text] [Related]

  • 10. [Beta adrenergic drugs in arterial hypertension].
    Gysling E.
    Union Med Can; 1972 Jul 17; 101(7):1336-41. PubMed ID: 4402882
    [No Abstract] [Full Text] [Related]

  • 11. Haemodynamic changes in patients with coronary heart disease after beta-adrenergic blockade with propranolol.
    Bürgin D.
    Int Z Klin Pharmakol Ther Toxikol; 1970 Oct 17; 4(4):365-70. PubMed ID: 4395489
    [No Abstract] [Full Text] [Related]

  • 12. [Metoprolol, a new cardioselective beta blocking agent in the treatment of arterial hypertension].
    Pedersen OL.
    Ugeskr Laeger; 1975 Sep 22; 137(39):2274-6. PubMed ID: 241148
    [No Abstract] [Full Text] [Related]

  • 13. [Behavior of cardiac output, plasma volume, plasma renin activity and aldosterone secretion in patients with essential hypertension treated with beta-blocking agents and diuretics].
    Salerno L, Licata G, Sparacino V, Custro N, Indovina I.
    Clin Ter; 1979 Aug 15; 90(3):223-32. PubMed ID: 45260
    [No Abstract] [Full Text] [Related]

  • 14. Hyperdynamic beta-adrenergic circulatory state. Increased beta-receptor responsiveness.
    Frohlich ED, Tarazi RC, Dustan HP.
    Arch Intern Med; 1969 Jan 15; 123(1):1-7. PubMed ID: 5761734
    [No Abstract] [Full Text] [Related]

  • 15. [Ambulatory antihypertensive therapy using the beta-receptor blockader obsidan].
    Dück KD, Knappe J, Strube G.
    Z Gesamte Inn Med; 1973 Aug 15; 28(16):Suppl:248-51. PubMed ID: 4767603
    [No Abstract] [Full Text] [Related]

  • 16. Verapamil in the management of chronic hypertension.
    Lewis GR.
    Clin Invest Med; 1980 Aug 15; 3(1-2):175-7. PubMed ID: 6110499
    [No Abstract] [Full Text] [Related]

  • 17. "Tailored" application of beta-blockers in hypertension: a continuing dilemma.
    Birkenhäger WH, de Leeuw PW, Wester A, Kho TL, Vandongen R, Falke HE.
    Neth J Med; 1977 Aug 15; 20(3):116-22. PubMed ID: 18688
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.
    Gilmore E, Weil J, Chidsey C.
    N Engl J Med; 1970 Mar 05; 282(10):521-7. PubMed ID: 4391708
    [No Abstract] [Full Text] [Related]

  • 19. [Mechanism of the antihypertensive action of propranolol].
    Magnani B, Ambrosioni E, Branzi A, Maresta A, Picchio F, Russo F, Sanguinetti M.
    Minerva Cardioangiol; 1973 Apr 05; 21(4):284-97. PubMed ID: 4710125
    [No Abstract] [Full Text] [Related]

  • 20. Hemodynamic studies on hypertension. II. Effects of isoproterenol, propranolol, noradrenaline and phentolamine on the hemodynamics in essential hypertension.
    Tsuchiya M.
    Jpn Circ J; 1972 Mar 05; 36(3):275-88. PubMed ID: 5068095
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.